Expertise providing comprehensive pre-commercial planning and reimbursement coverage, commercial launch effectiveness and commercial compliance risk management advisory services to companies across the medical device and pharmaceutical industries.
Translating innovative research to address a market need can be an intricate exercise with many potential pitfalls. Organizations require a dynamic strategy that aligns the activities of commercial and medical affairs and that is driven by clinical outcomes, supported by real-world evidence.
Our specialized professionals understand the intricacies of navigating the complex demands of physicians, hospital systems and payers to ensure patients’ fair and equitable access to novel therapies. These solutions take into account product pricing, reimbursement, life cycle management, and real-world evidence, in developing global commercialization plans as well as enabling medical affairs platforms.
Our market access strategy and support services assist companies in balancing pricing, reimbursement and market demand decisions. Thoughtful program design and execution enables our clients to sustain market penetration from launch through the product lifecycle. Our approach includes:
Baker Tilly’s focus on being a Value Architect™ means we remain engaged with our clients to support their ongoing strategy execution through ongoing support solutions, including: